Novel Cephalosporins Synthesized by Amination of 2,5-Dihydroxybenzoic Acid Derivatives Using Fungal Laccases 2
-
- Mikolasch Annett
- Institute of Microbiology, Ernst-Moritz-Arndt-University Greifswald
-
- Niedermeyer Timo Horst Johannes
- Institute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald
-
- Lalk Michael
- Institute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald
-
- Witt Sabine
- Ganomycin Society of Biomedical Research Ltd.
-
- Seefeldt Simone
- Ganomycin Society of Biomedical Research Ltd.
-
- Hammer Elke
- Institute of Microbiology, Ernst-Moritz-Arndt-University Greifswald
-
- Schauer Frieder
- Institute of Microbiology, Ernst-Moritz-Arndt-University Greifswald
-
- Gesell Salazar Manuela
- Institute of Marine Biotechnology
-
- Hessel Susanne
- Institute of Marine Biotechnology
-
- Jülich Wolf-Dieter
- Institute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald
-
- Lindequist Ulrike
- Institute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald
書誌事項
- タイトル別名
-
- Novel Cephalosporins Synthesized by Amination of 2,5-Dihydroxybenzoic Acid Derivatives Using Fungal Laccases II
この論文をさがす
説明
Sixteen novel cephalosporins were synthesized by amination of 2,5-dihydroxybenzoic acid derivatives with the aminocephalosporins cefadroxil, cefalexin, cefaclor, and the structurally related carbacephem loracarbef using laccases from Trametes sp. or Myceliophthora thermophila. All products inhibited the growth of several Gram positive bacterial strains in the agar diffusion assay, among them methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. The products protected mice against an infection with Staphylococcus aureus lethal to the control animals. Cytotoxicity and acute toxicity of the new compounds were negligible. The results show the usefulness of laccase for the synthesis of potential new antibiotics. The biological activity of the new compounds stimulates intensified pharmacological tests.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 55 (3), 412-416, 2007
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204169146496
-
- NII論文ID
- 110006225091
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 8658154
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可